A Prospective Stratified Case-Cohort Study on Statins and Multiple Adverse Events in Japan

• Nobuhiro Ooba ,

  * E-mail: n-ooba@umin.net

  Affiliation Department of Pharmacoepidemiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

  ⨯
• Tsugumichi Sato,

  Affiliations Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan, Drug Safety Research Unit Japan, Tokyo, Japan

  ⨯
• Akira Wakana,

  Affiliation MSD K.K., Tokyo, Japan

  ⨯
• Takao Orii,

  Affiliation NTT Medical Center Tokyo, Tokyo, Japan

  ⨯
• Masaki Kitamura,

  Affiliation Department of Pharmacy, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Akira Kokan,

  Affiliation EliLilly Japan, K.K., Hyogo, Japan

  ⨯
• Hideaki Kurata,

  Affiliation Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Yoshihiro Shimodozono,

  Affiliation Department of Clinical Pharmacy and Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

  ⨯
• Kenichi Matsui,

  Affiliation Office for Promoting Medical Research, Showa University, Tokyo, Japan

  ⨯
• Hiroshi Yoshida,

  Affiliation Department of Laboratory Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan

  ⨯
• Takuhiro Yamaguchi,

  Affiliation Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan

  ⨯
• Shigeru Kageyama,

  Affiliation Division of Clinical Pharmacology and Therapeutics, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Kiyoshi Kubota

  Affiliation Department of Pharmacoepidemiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

  ⨯